SCHEMBL17599436

SCHEMBL17599436

CCOC(=O)C1CCCN(c2ccc(NS(=O)(=O)c3c(C)c(C)cc(C)c3C)c3cccnc23)C1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KEAP1 Q14145 4/20 0.74
▸ NFE2L2 Q16236 1/20 0.56
▸ NPSR1 Q6W5P4 4/20 0.50
▸ TSHR P16473 2/20 0.50
▸ ALDH1A1 P00352 6/20 0.48
▸ CTSB P07858 2/20 0.48
▸ BRD4 O60885 1/20 0.48
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ MAPT P10636 2/20 0.46
▸ USP2 O75604 1/20 0.46
▸ POLB P06746 1/20 0.46
▸ THRB P10828 1/20 0.46
▸ S100A4 P26447 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ RECQL P46063 1/20 0.46
▸ MAPK1 P28482 2/20 0.44
▸ PLAUR Q03405 1/20 0.43
▸ GAA P10253 1/20 0.42
▸ HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599439 0.90 KEAP1 (0.90) KEAP1NFE2L2ALDH1A1CTSBMEN1
SCHEMBL17612852 0.88 KEAP1 (0.71) KEAP1NFE2L2NPSR1TSHRALDH1A1
SCHEMBL17599447 0.88 KEAP1 (0.71) KEAP1NFE2L2NPSR1TSHRALDH1A1
SCHEMBL17612859 0.88 KEAP1 (0.71) KEAP1NFE2L2NPSR1TSHRALDH1A1
SCHEMBL17599451 0.85 KEAP1 (1.00) KEAP1NFE2L2ALDH1A1CTSBMEN1
SCHEMBL17599418 0.85 KEAP1 (1.00) KEAP1NFE2L2ALDH1A1CTSBMEN1
SCHEMBL17612884 0.85 KEAP1 (1.00) KEAP1NFE2L2ALDH1A1CTSBMEN1
SCHEMBL17599548 0.79 NPSR1 (0.53) KEAP1NFE2L2NPSR1TSHRALDH1A1
SCHEMBL17599417 0.78 KEAP1 (0.89) KEAP1NFE2L2NPSR1TSHRALDH1A1
SCHEMBL17599488 0.78 KEAP1 (0.89) KEAP1NFE2L2NPSR1TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2997966-A1 Naphthyl Sulfonamide Pyrrolidine Derivatives as KEAP-1 Modulators for the Treatment of Diabetes, Obesity, Dyslipidemia and Related Disorders SANOFI (FR) 2016-03-23 — — EP disclosed
Send feedback